SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-23-151524
Filing Date
2023-05-23
Accepted
2023-05-23 12:49:56
Documents
2
Group Members
JAMES MCNULTY

Document Format Files

Seq Description Document Type Size
1 SC 13D d482133dsc13d.htm SC 13D 53926
2 EX-99.1 d482133dex991.htm EX-99.1 3615
  Complete submission text file 0001193125-23-151524.txt   59274
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Subject) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-51823 | Film No.: 23947703
SIC: 2834 Pharmaceutical Preparations

Mailing Address 900 WEST PLATT STREET SUITE 200 TAMPA FL 33606
Business Address 900 WEST PLATT STREET SUITE 200 TAMPA FL 33606 8138642562
Black Robe Capital LLC (Filed by) CIK: 0001977553 (see all company filings)

IRS No.: 431271749 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13D